This 13-minute slideshow reviews patient- and treatment-related factors that influence an individual’s risk for chemotherapy-induced nausea and vomiting (CINV). Also see “Emetogenic Risk of Chemotherapy and Biotherapy Agents,” a guide for calculating a regimen’s risk for causing CINV.
The incidence of oral mucositis varies across populations of patients with cancer and is related to individual patient factors and the type of therapy being received. Standard-dose chemotherapy: 40% incidence Hematopoietic stem cell transplantation: 80% incidence Radiation therapy for head and neck cancers: nearly 100% incidence The following table and figures provide more information about risk factors for oral mucositis.
Genetics Online Education Series This series consists of six separate lessons that will provide participants with an introduction to genetics. Topics include the genetic basis of cancer; DNA structure and function; DNA mutations; how DNA damage is repaired; chromosome abnormalities; gene regulation; and inheritance patterns of diseases, including complex diseases.